149 related articles for article (PubMed ID: 19066290)
21. Mitogen-activated protein kinase signaling enhances sodium iodide symporter function and efficacy of radioiodide therapy in nonthyroidal cancer cells.
Jung KH; Paik JY; Ko BH; Lee KH
J Nucl Med; 2008 Dec; 49(12):1966-72. PubMed ID: 18997042
[TBL] [Abstract][Full Text] [Related]
22. A novel loss-of-function deletion in sodium/iodide symporter gene in follicular thyroid adenoma.
Liang JA; Chen CP; Huang SJ; Ho TY; Hsiang CY; Ding HJ; Wu SL
Cancer Lett; 2005 Dec; 230(1):65-71. PubMed ID: 16253762
[TBL] [Abstract][Full Text] [Related]
23. AFP promoter enhancer increased specific expression of the human sodium iodide symporter (hNIS) for targeted radioiodine therapy of hepatocellular carcinoma.
Ma XJ; Huang R; Kuang AR
Cancer Invest; 2009 Jul; 27(6):673-81. PubMed ID: 19241193
[TBL] [Abstract][Full Text] [Related]
24. Effects of perchlorate on sodium-iodide symporter and pendrin gene expression in deer mice.
Cheng Q; Smith EE; Liu F; Gentle A; Hooper MJ; Anderson TA
Environ Toxicol; 2007 Aug; 22(4):390-8. PubMed ID: 17607730
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and evaluation of 3,4-dihydropyrimidin-2(1H)-ones as sodium iodide symporter inhibitors.
Lacotte P; Puente C; Ambroise Y
ChemMedChem; 2013 Jan; 8(1):104-11. PubMed ID: 23132843
[TBL] [Abstract][Full Text] [Related]
26. Xanthohumol stimulates iodide uptake in rat thyroid-derived FRTL-5 cells.
Radović B; Schmutzler C; Köhrle J
Mol Nutr Food Res; 2005 Sep; 49(9):832-6. PubMed ID: 16092068
[TBL] [Abstract][Full Text] [Related]
27. Comparison of expressed human and mouse sodium/iodide symporters reveals differences in transport properties and subcellular localization.
Dayem M; Basquin C; Navarro V; Carrier P; Marsault R; Chang P; Huc S; Darrouzet E; Lindenthal S; Pourcher T
J Endocrinol; 2008 Apr; 197(1):95-109. PubMed ID: 18372236
[TBL] [Abstract][Full Text] [Related]
28. Development of a screening approach to detect thyroid disrupting chemicals that inhibit the human sodium iodide symporter (NIS).
Hallinger DR; Murr AS; Buckalew AR; Simmons SO; Stoker TE; Laws SC
Toxicol In Vitro; 2017 Apr; 40():66-78. PubMed ID: 27979590
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of potential sodium-iodide symporter (NIS) inhibitors using a secondary Fischer rat thyroid follicular cell (FRTL-5) radioactive iodide uptake (RAIU) assay.
Buckalew AR; Wang J; Murr AS; Deisenroth C; Stewart WM; Stoker TE; Laws SC
Arch Toxicol; 2020 Mar; 94(3):873-885. PubMed ID: 32065294
[TBL] [Abstract][Full Text] [Related]
30. Use of the thyrocyte sodium iodide symporter as the basis for a perchlorate cell-based assay.
MacAllister IE; Jakoby MG; Geryk B; Schneider RL; Cropek DM
Analyst; 2009 Feb; 134(2):320-4. PubMed ID: 19173056
[TBL] [Abstract][Full Text] [Related]
31. The Sodium/Iodide Symporter (NIS): Molecular Physiology and Preclinical and Clinical Applications.
Ravera S; Reyna-Neyra A; Ferrandino G; Amzel LM; Carrasco N
Annu Rev Physiol; 2017 Feb; 79():261-289. PubMed ID: 28192058
[TBL] [Abstract][Full Text] [Related]
32. [The practical relevance of the sodium iodide symporter].
Spitzweg C
Z Arztl Fortbild Qualitatssich; 2004 May; 98 Suppl 5():25-32. PubMed ID: 15255310
[TBL] [Abstract][Full Text] [Related]
33. Anion selectivity by the sodium iodide symporter.
Van Sande J; Massart C; Beauwens R; Schoutens A; Costagliola S; Dumont JE; Wolff J
Endocrinology; 2003 Jan; 144(1):247-52. PubMed ID: 12488351
[TBL] [Abstract][Full Text] [Related]
34. Synthesis, evaluation and absolute configuration assignment of novel dihydropyrimidin-2-ones as picomolar sodium iodide symporter inhibitors.
Lacotte P; Buisson DA; Ambroise Y
Eur J Med Chem; 2013 Apr; 62():722-7. PubMed ID: 23454514
[TBL] [Abstract][Full Text] [Related]
35. Histidine residue at position 226 is critical for iodide uptake activity of human sodium/iodide symporter.
Wu SL; Ho TY; Liang JA; Hsiang CY
J Endocrinol; 2008 Nov; 199(2):213-9. PubMed ID: 18708479
[TBL] [Abstract][Full Text] [Related]
36. Cell-based imaging of sodium iodide symporter activity with the yellow fluorescent protein variant YFP-H148Q/I152L.
Rhoden KJ; Cianchetta S; Stivani V; Portulano C; Galietta LJ; Romeo G
Am J Physiol Cell Physiol; 2007 Feb; 292(2):C814-23. PubMed ID: 16987991
[TBL] [Abstract][Full Text] [Related]
37. The Na+/I- symporter mediates active iodide uptake in the intestine.
Nicola JP; Basquin C; Portulano C; Reyna-Neyra A; Paroder M; Carrasco N
Am J Physiol Cell Physiol; 2009 Apr; 296(4):C654-62. PubMed ID: 19052257
[TBL] [Abstract][Full Text] [Related]
38. Retinol has specific effects on binding of thyrotrophin to cultured porcine thyrocytes.
Fröhlich E; Witke A; Czarnocka B; Wahl R
J Endocrinol; 2004 Dec; 183(3):617-26. PubMed ID: 15590987
[TBL] [Abstract][Full Text] [Related]
39. [
Jiang H; DeGrado TR
Theranostics; 2018; 8(14):3918-3931. PubMed ID: 30083270
[TBL] [Abstract][Full Text] [Related]
40. Endogenous NIS expression in triple-negative breast cancers.
Renier C; Yao C; Goris M; Ghosh M; Katznelson L; Nowles K; Gambhir SS; Wapnir I
Ann Surg Oncol; 2009 Apr; 16(4):962-8. PubMed ID: 19184238
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
